RASopathic Skin Eruptions during Vemurafenib Therapy

PURPOSE: Vemurafenib is a potent inhibitor of V600 mutant BRAF with significant impact on progression-free and overall survival in advanced melanoma. Cutaneous side effects are frequent. This single-center observational study investigates clinical and histological features of these class-specific cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinderknecht, Jeannine D., Goldinger, Simone M., Rozati, Sima, Kamarashev, Jivko, Kerl, Katrin, French, Lars E., Dummer, Reinhard, Belloni, Benedetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597638/
https://www.ncbi.nlm.nih.gov/pubmed/23516541
http://dx.doi.org/10.1371/journal.pone.0058721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597638/
https://www.ncbi.nlm.nih.gov/pubmed/23516541
http://dx.doi.org/10.1371/journal.pone.0058721

Ejemplares similares